ASX:SRX - Sirtex Medical Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous CloseA$33.55
Today's RangeA$33.55 - A$33.55
52-Week RangeA$10.45 - A$33.58
VolumeN/A
Average Volume959,639 shs
Market CapitalizationN/A
P/E Ratio45.96
Dividend Yield0.89%
BetaN/A
Sirtex Medical Limited, a life-sciences company, develops and delivers oncology treatments using novel small particle technology in the Asia-Pacific, Europe, the Middle East, Africa, and North and South America. The company's principal product is the SIR-Spheres Y-90 resin microspheres, a targeted radioactive treatment for primary and secondary metastatic liver cancer. Sirtex Medical Limited is headquartered in North Sydney, Australia.

Receive SRX News and Ratings via Email

Sign-up to receive the latest news and ratings for SRX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+61-2-99648400

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$218.74 million
Book ValueA$2.85 per share

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Sirtex Medical (ASX:SRX) Frequently Asked Questions

What is Sirtex Medical's stock symbol?

Sirtex Medical trades on the ASX under the ticker symbol "SRX."

Has Sirtex Medical been receiving favorable news coverage?

Media stories about SRX stock have trended somewhat negative recently, InfoTrie Sentiment Analysis reports. InfoTrie scores the sentiment of news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Sirtex Medical earned a news impact score of -1.1 on InfoTrie's scale. They also gave media headlines about the medical device company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the next several days.

Who are some of Sirtex Medical's key competitors?

What other stocks do shareholders of Sirtex Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sirtex Medical investors own include Woodside Petroleum (WPL), REA Group (REA), Bristol-Myers Squibb (BMY), Mantra Group (MTR), IMF Bentham (IMF), Galaxy Resources (GXY), Crown Resorts (CWN), Caltex Australia (CTX), Corporate Travel Management (CTD) and CSL (CSL).

Who are Sirtex Medical's key executives?

Sirtex Medical's management team includes the folowing people:
  • Mr. Andrew McLean, CEO, MD Exec. Director
  • Mr. Darren Smith M.B.A., B.Bus., FCPA, CFO & Company Sec. (Age 53)
  • Mr. Anthony Dixon, Exec. VP of Sales & Marketing - EMEA
  • Mr. G. Spindler, Global Head of Operations
  • Dr. Thomas Duthy, Global Head of Investor Relations & Corp. Devel.

What is Sirtex Medical's official website?

The official website for Sirtex Medical is http://www.sirtex.com/ap/.

How can I contact Sirtex Medical?

Sirtex Medical's mailing address is L 33 101 Miller St, NORTH SYDNEY, NSW 2060, Australia. The medical device company can be reached via phone at +61-2-99648400.


MarketBeat Community Rating for Sirtex Medical (ASX SRX)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  70 (Vote Outperform)
Underperform Votes:  95 (Vote Underperform)
Total Votes:  165
MarketBeat's community ratings are surveys of what our community members think about Sirtex Medical and other stocks. Vote "Outperform" if you believe SRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SRX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/25/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel